Search is Powered by Google
Alzheimer's / Dementia News

Alzhemier's Research Trust Funding For Essex

Main Category: Alzheimer's / Dementia
Article Date: 01 Oct 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The Department of Biological Sciences at the University of Essex has received over £27,000 from the Alzheimer's Research Trust. Dr Jody Mason, a lecturer within the Department, will use this grant to undertake research regarding dementia patients.

Dr Mason explains: 'In neurodegenerative diseases such as Alzheimer's or Parkinson's, aggregation (or clumping) of proteins into toxic fibrils (or chains) is considered to be the key pathogenic event. However, no therapeutic agents currently exist to control this process. In particular, two proteins known as ß-amyloid and a-synuclein aggregate into fibrils, forming amyloid plaques and Lewy bodies that are characteristic of these diseases. A problem arises, however, in antagonist development; in recent years it has become established that small soluble (protofibrillar) forms of amyloid are the neurotoxic species, and that larger fibrils rather serve as reservoirs for these smaller protofibrils.'

'Unfortunately, peptides and drugs designed to prevent amyloid have until recently been concerned with removing these larger fibrillar deposits. If compounds designed to breakdown amyloid are only partially effective then the balance will be shifted in the direction of smaller protofibrillar forms, rendering the amyloid more toxic in the process. We will use our expertise in the amyloid, protein-protein interaction, and library screening and design fields to combat this.'

This grant application follows on from Dr Mason's previous experience in the field. There are currently 700,000 people living with dementia in the UK, this will rise to more than a million in less than 20 years. At present, dementia costs the UK around £17 billion each year. Development of drugs capable of slowing or stopping the onset of Alzheimer's or Parkinson's disease would improve the lives of millions of sufferers worldwide.

UNIVERSITY OF ESSEX
Wivenhoe Park
Colchester
CO4 3SQ
http:// www.essex.ac.uk




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Using Creativity to Combat Alzheimer's image Using Creativity to Combat Alzheimer's

Learn how the introduction of a new activity changed the lives of an Alzheimer's patient and her caregiver...

Diagnosing Alzheimer's Early image Diagnosing Alzheimer's Early

Early diagnosis of Alzheimer's disease is critical to delaying the effects of the disease. Additonally, the earlier the diagnosis, the more time patients and caregivers have to plan for the future...

View more videos...